Safety Information
For a full list of warnings, precautions, and adverse events related to H.P. Acthar® Gel (repository corticotropin injection), please refer to the full Prescribing Information and discuss this information with your healthcare provider.
Acthar should not be used by persons with any of the following conditions:
- Scleroderma
- Osteoporosis
- Systemic fungal infections
- Ocular herpes simplex
- Recent surgery
- History of or the presence of a peptic ulcer
- Congestive heart failure
- Hypertension
- Allergies to pork or pork products
Please tell your healthcare provider if you have any of these conditions.
Potential Side Effects
Acthar has been used for more than 25 years and has a well-established safety profile.
Common adverse reactions associated with the use of Acthar Gel include:
- diarrhea
- fluid retention
- headache
- hirsutism
- increased sweating
- injection site reaction
- mood alteration
- skin reactions
- tachycardia and palpitations
- vertigo
Other, potentially serious adverse reactions may also occur:
- abscess
- anaphylaxis
- congestive heart failure
- convulsions
- Cushingoid state
- electrolyte disturbances
- glucose intolerance
- hypertension
- impaired wound healing
- increased intraocular pressure
- muscle weakness
- osteoporosis
- pancreatitis
- peptic ulcer; ulcerative esophagitis
- posterior subcapsular cataracts
- psychotic state
- severe allergic reaction
- suppression of growth in children
For a full list of adverse events for Acthar, please refer to the package insert and discuss this information with your healthcare provider.
Drug Interactions
Acthar may accentuate the electrolyte loss associated with diuretic use. Other drug interactions are possible. Please consult with your healthcare provider.